Rhinitis, Cognition and Driving Performance

• Status: Completed
• Trial end date: 2012-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study investigates the effects of Allergic Rhinitis (AR) on driving ability and memory functions. Our group has previously shown that patients suffering from AR symptoms perform less well on tasks requiring sustained attention compared to non symptomatic controls. Car driving is a typical behavior that is susceptible for changes in sustained attention and might therefore become worse under conditions when patients suffer from AR symptoms. We will compare the driving performance of untreated, symptomatic AR patients with the performance of symptomatic patients that have been treated with either a systemic AR medication (a pill) or a topical medication (nasal spray)

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Maastricht University Medical Center
• Treatments: Cetirizine; Fluticasone; Xhance

Criteria

Inclusion Criteria:

• Healthy volunteers known with Seasonal Allergic Rhinitis

• Experienced drivers holding a license

• 21- 45 years of age

Exclusion Criteria:

• Asthma or other chronic illness

• current psychoactive medication

• History of drug abuse